Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • Reporting Rate Calculator
  • Signal Detection
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Myocarditis
  • Guillain-Barré
  • Allergic Reactions
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenImmigration
  • OpenSubsidies
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • WarCosts
  • OpenPrescriber
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Hib (Pedvaxhib)
  4. Haemorrhage intracranial
Hib (Pedvaxhib)×Haemorrhage intracranial

Haemorrhage intracranial Reports for Hib (Pedvaxhib)

#845 most reported symptom for this vaccine

14
Reports
3
Deaths
11
Hospitalizations
21.43
Mortality Rate
%
78.6
Hosp. Rate
%

Haemorrhage intracranial and Hib (Pedvaxhib)

Haemorrhage intracranial has been reported 14 times in association with Hib (Pedvaxhib) vaccination in VAERS. This represents 0.0% of all 60,298 reports for this vaccine.

Among these reports, 3 mentioned death (21.43%) and 11 involved hospitalization (78.6%).

Haemorrhage intracranial is the #845 most frequently reported symptom for Hib (Pedvaxhib) out of 2013 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 14 reports of Haemorrhage intracranial after Hib (Pedvaxhib) vaccination may seem alarming, but context is critical.

The 21.43% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.

Important Context

•Association, not causation: These reports show Haemorrhage intracranial occurred after vaccination, not that the vaccine caused it.
•Background rates: Haemorrhage intracranial may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Herpes simplex test negative15 reportsInfantile apnoea15 reportsPhotosensitivity reaction14 reportsPost vaccination syndrome14 reports

Quick Facts

Reports:14
Deaths:3
Hospitalizations:11
% of Vaccine:0.0%
Rank:#845 of 2013

Related Pages

Hib (Pedvaxhib) OverviewHaemorrhage intracranial (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.